206 related articles for article (PubMed ID: 18679116)
1. Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis.
Cirioni O; Ghiselli R; Orlando F; Silvestri C; De Luca S; Salzano AM; Mocchegiani F; Saba V; Scalise G; Scaloni A; Giacometti A
Crit Care Med; 2008 Sep; 36(9):2629-33. PubMed ID: 18679116
[TBL] [Abstract][Full Text] [Related]
2. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
3. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
[TBL] [Abstract][Full Text] [Related]
4. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
[TBL] [Abstract][Full Text] [Related]
5. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Ĺukasiak J; Saba V; Scalise G
J Infect Dis; 2005 Nov; 192(9):1613-20. PubMed ID: 16206076
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
[TBL] [Abstract][Full Text] [Related]
7. Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
Cirioni O; Silvestri C; Ghiselli R; Giacometti A; Orlando F; Mocchegiani F; Chiodi L; Vittoria AD; Saba V; Scalise G
Peptides; 2006 Nov; 27(11):2600-6. PubMed ID: 16797106
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
11. Effect of teicoplanin and G-CSF on survival in experimental MRSA pneumonia in neutropenic mice.
Oz N; Agalar C; Daphan CE; Agalar F; Turkyilmaz R
Int J Surg Investig; 2001; 2(5):347-52. PubMed ID: 12678538
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.
Cirioni O; Silvestri C; Ghiselli R; Orlando F; Riva A; Gabrielli E; Mocchegiani F; Cianforlini N; Trombettoni MM; Saba V; Scalise G; Giacometti A
Crit Care Med; 2009 Apr; 37(4):1403-7. PubMed ID: 19318826
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.
Ghiselli R; Cirioni O; Giacometti A; Scalise A; Simonetti O; Mocchegiani F; Orlando F; Goteri G; Della Vittoria A; Filosa A; Silvestri C; Offidani A; Bertani A; Scalise G; Saba V
J Surg Res; 2008 Jan; 144(1):74-81. PubMed ID: 17574587
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds.
Simonetti O; Cirioni O; Ghiselli R; Goteri G; Orlando F; Monfregola L; De Luca S; Zizzi A; Silvestri C; Veglia G; Giacometti A; Guerrieri M; Offidani A; Scaloni A
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3047-55. PubMed ID: 22729599
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
[TBL] [Abstract][Full Text] [Related]
16. The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Bergnach C; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Skerlavaj B; Saba V; Zanetti M; Scalise G
Crit Care Med; 2004 Dec; 32(12):2485-90. PubMed ID: 15599155
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.
Cirioni O; Ghiselli R; Tomasinsig L; Orlando F; Silvestri C; Skerlavaj B; Riva A; Rocchi M; Saba V; Zanetti M; Scalise G; Giacometti A
Shock; 2008 Oct; 30(4):443-8. PubMed ID: 18391859
[TBL] [Abstract][Full Text] [Related]
18. Effect of cornuside on experimental sepsis.
Jiang WL; Chen XG; Zhu HB; Tian JW
Planta Med; 2009 May; 75(6):614-9. PubMed ID: 19263342
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Del Prete MS; Licci A; D'Amato G; Lukasiak J; Scalise G
J Antimicrob Chemother; 2005 Aug; 56(2):410-2. PubMed ID: 15983026
[TBL] [Abstract][Full Text] [Related]
20. Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.
Simonetti O; Cirioni O; Goteri G; Ghiselli R; Kamysz W; Kamysz E; Silvestri C; Orlando F; Barucca C; Scalise A; Saba V; Scalise G; Giacometti A; Offidani A
Peptides; 2008 Apr; 29(4):520-8. PubMed ID: 18255189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
